Literature DB >> 11720854

Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weight.

K G Liu1, M H Lambert, A H Ayscue, B R Henke, L M Leesnitzer, W R Oliver, K D Plunket, H E Xu, D D Sternbach, T M Willson.   

Abstract

A series of PPARgamma agonists were synthesized from L-tyrosine that incorporated low molecular weight N-substituents. The most potent analogue, pyrrole (4e), demonstrated a K(i) of 6.9nM and an EC(50) of 4.7nM in PPARgamma binding and functional assays, respectively. Pyrrole (4e), which is readily synthesized from L-tyrosine methyl ester in four steps, also demonstrated in vivo activity in a rodent model of Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720854     DOI: 10.1016/s0960-894x(01)00649-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation.

Authors:  Darren L Reid; C Jeffrey Calvitt; Mark T Zell; Kenneth G Miller; Carol A Kingsmill
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

2.  Pharmacophore modeling and parallel screening for PPAR ligands.

Authors:  Patrick Markt; Daniela Schuster; Johannes Kirchmair; Christian Laggner; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.